minimum residual disease
However, CD38 is an important marker for plasma cell detection by flowcytometry, the use of daratumumab will affect the assessment of plasma cell population, as well as the investigation of minimum residual disease (MRD) using this technique.
However, CD38 is an important marker for plasma cell detection by flowcytometry, the use of daratumumab will affect the assessment of plasma cell population, as well as the investigation of minimum residual disease ( MRD ) using this technique .